Skip to content
10-Q

Quarterly Report

DOLBY LABORATORIES, INC. DLB

0001308547-26-000010

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2026 · Mar 27, 2026 95.52M sh
Shares Diluted Q2 2026 · Mar 27, 2026 96.27M sh
Shares Diluted Q2 2026 · Mar 28, 2025 97.47M sh
Shares Diluted Q2 2026 · Mar 28, 2025 97.58M sh
Stock Repurchased Q2 2026 · Mar 27, 2026 $65M
Stock Repurchased Q2 2026 · Mar 27, 2026 $135M
Stock Repurchased Q2 2026 · Dec 26, 2025 $70.01M
Stock Repurchased Q2 2026 · Mar 28, 2025 $50M
Dividends Paid Q2 2026 · Mar 27, 2026 $68.67M
Dividends Paid Q2 2026 · Mar 28, 2025 $63.38M
Capex Q2 2026 · Mar 27, 2026 $13.69M
Capex Q2 2026 · Mar 28, 2025 $13.68M
Operating Cash Flow Q2 2026 · Mar 27, 2026 $147.31M
Operating Cash Flow Q2 2026 · Mar 28, 2025 $281.68M
Short Term Investments Q2 2026 · Mar 27, 2026 $460K
Short Term Investments Q2 2026 · Sep 26, 2025 $703K
Cash And Equivalents Q2 2026 · Mar 27, 2026 $594.28M
Cash And Equivalents Q2 2026 · Sep 26, 2025 $701.89M
Stockholders Equity Q2 2026 · Mar 27, 2026 $2.62B
Stockholders Equity Q2 2026 · Sep 26, 2025 $2.62B
Current Liabilities Q2 2026 · Mar 27, 2026 $474.61M
Current Liabilities Q2 2026 · Sep 26, 2025 $437.79M
Total Liabilities Q2 2026 · Mar 27, 2026 $622.36M
Total Liabilities Q2 2026 · Sep 26, 2025 $595.81M
Current Assets Q2 2026 · Mar 27, 2026 $1.41B
Current Assets Q2 2026 · Sep 26, 2025 $1.39B
Total Assets Q2 2026 · Mar 27, 2026 $3.25B
Total Assets Q2 2026 · Sep 26, 2025 $3.23B
Eps Diluted Q2 2026 · Mar 27, 2026 $0.99
Eps Diluted Q2 2026 · Mar 27, 2026 $1.54
Eps Diluted Q2 2026 · Mar 28, 2025 $0.94
Eps Diluted Q2 2026 · Mar 28, 2025 $1.64
Eps Basic Q2 2026 · Mar 27, 2026 $1.00
Eps Basic Q2 2026 · Mar 27, 2026 $1.55
Eps Basic Q2 2026 · Mar 28, 2025 $0.95
Eps Basic Q2 2026 · Mar 28, 2025 $1.66
Sga Expense Q2 2026 · Mar 27, 2026 $75.96M
Sga Expense Q2 2026 · Mar 27, 2026 $146.2M
Sga Expense Q2 2026 · Mar 28, 2025 $70.42M
Sga Expense Q2 2026 · Mar 28, 2025 $140.51M
Rd Expense Q2 2026 · Mar 27, 2026 $63.65M
Rd Expense Q2 2026 · Mar 27, 2026 $132.73M
Rd Expense Q2 2026 · Mar 28, 2025 $61.71M
Rd Expense Q2 2026 · Mar 28, 2025 $128.35M
Net Income Q2 2026 · Mar 27, 2026 $94.92M
Net Income Q2 2026 · Mar 27, 2026 $148.24M
Net Income Q2 2026 · Mar 28, 2025 $91.79M
Net Income Q2 2026 · Mar 28, 2025 $159.62M
Operating Income Q2 2026 · Mar 27, 2026 $112.95M
Operating Income Q2 2026 · Mar 27, 2026 $175.11M
Operating Income Q2 2026 · Mar 28, 2025 $107.76M
Operating Income Q2 2026 · Mar 28, 2025 $187.64M
Gross Profit Q2 2026 · Mar 27, 2026 $350.9M
Gross Profit Q2 2026 · Mar 27, 2026 $654.4M
Gross Profit Q2 2026 · Mar 28, 2025 $333.72M
Gross Profit Q2 2026 · Mar 28, 2025 $649.95M
Cost Of Revenue Q2 2026 · Mar 27, 2026 $44.73M
Cost Of Revenue Q2 2026 · Mar 27, 2026 $87.94M
Cost Of Revenue Q2 2026 · Mar 28, 2025 $35.84M
Cost Of Revenue Q2 2026 · Mar 28, 2025 $76.61M
Revenue Q2 2026 · Mar 27, 2026 $395.63M
Revenue Q2 2026 · Mar 27, 2026 $742.34M
Revenue Q2 2026 · Mar 28, 2025 $369.56M
Revenue Q2 2026 · Mar 28, 2025 $726.56M